The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Tozinameran (mRNA Covid 19 vaccine)
Australian Public Assessment Report
Device/Product Name
Comirnaty
Active ingredients
Tozinameran (mRNA Covid 19 vaccine)
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-05012-1-2
Submission Type
Extension of indications; change to formulation (excipients)
Decision
Approved